Accelerate Diagnostics Inc (NASDAQ:AXDX), saw 10% Owner and Director Jack W. Schuler raise his stake in the company with transactions beginning this week. Schuler acquired 10,000 shares of common stock at prices ranging from $26 to $26.1 per share. Following the transaction, Schuler now indirectly owns 10,649,992 shares in the $1.16 billion market cap Diagnostics corporation. In addition to Schuler, some of the major hedge funds with holdings in Accelerate Diagnostics Inc (NASDAQ:AXDX) have shown movement as well. Joseph A. Jolson’s Harvest Capital Strategies has lowered it’s activity by 54%, with 55,000 shares worth about $1.2 million; Cliff Asness’ Aqr Capital Managment…
Author: Daniel Forstein
OHR Pharmaceutical Inc (NASDAQ:OHRP), saw Director Sherie June Almenoff increase her stake in the company. Almenoff purchased 3,200 shares at an average of $8.34 per share. This is not the first move this director has made this year, as Almenoff purchased over 5,000 shares in the company’s common stock this past April. Following these transactions, Almenoff directly owns 125,366 shares in the $221 million market cap pharmaceutical corporation. Four major Hedge Funds have holdings in the company, & all have remained steady over the past quarter, showing neither an increase or decrease in their exposure to OHR Pharmaceutical Inc (NASDAQ:OHRP). Israel Englander’s Millennium…
Monmouth R.E. Inv. Corp. (NYSE:MNR), watched Director & Chairman of the Board Eugene W. Landy increase his position in the company’s common stock by 13,000 shares. Landy acquired 65,000 shares at an average of $8.15 per share; while also unloading 52,000 shares at a range of $9.85 to $9.95 per share. After these transactions, Landy directly owns 706,400 shares in the company and 709,881 shares indirectly. Furthermore, some hedge funds have shown vast movement in participation with Monmouth R.E. Inv. Corp. (NYSE:MNR) while others have remained steady in their holdings in the $556.6 million dollar company. John Overdeck And David Siegel’s Two Sigma Advisors has…
Boston Beer Co Inc (NYSE:SAM), saw Chairman, Director, and 10% Owner James C. Kotch drop shares in the company’s common stock over the past few days. These disposals were completed in two sales, starting last Thursday, where the Director unloaded 4,000 shares at a range of $220.4 to $222.75 per share. On Friday, Kotch disposed of 4,000 more shares at a range of $220.5 to $224 per share. This is the latest string of sales from Kotch, who has continued to drop shares in the company throughout June. Following the reported transactions, Kotch directly owns 74,032 shares, while indirectly owning 213,922…